We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current XBIO market cap is 6.45M. The company's latest EPS is USD -2.6813 and P/E is -1.55.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 611k | 672k | 511k | 726k | 614k |
| Operating Income | -1.15M | -1.26M | -1.27M | -1.34M | -500k |
| Net Income | -1.06M | -1.17M | -1.2M | -1.27M | -437k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17k | 437k | 1.16M | 1.71M | 2.54M |
| Operating Income | -12.89M | -13.94M | -5.75M | -6.72M | -4.52M |
| Net Income | -18.06M | -10.89M | -5.65M | -6.55M | -4.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.96M | 10.61M | 9.39M | 9.03M | 8.05M |
| Total Liabilities | 1.07M | 809k | 716k | 1.59M | 1.01M |
| Total Equity | 10.89M | 9.8M | 8.68M | 7.45M | 7.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.55M | 13.18M | 19.82M | 14.72M | 10.61M |
| Total Liabilities | 4.33M | 963k | 1.42M | 1.07M | 809k |
| Total Equity | 17.21M | 12.22M | 18.39M | 13.65M | 9.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.32M | -4.11M | -1.16M | -1.68M | -2.14M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.4M | -4.27M | -4.74M | -4.65M | -4.11M |
| Investing | 2k | N/A | N/A | -500k | N/A |
| Financing | 16.13M | 5.43M | 11.45M | N/A | N/A |
| Market Cap | 6.45M |
| Price to Earnings Ratio | -1.55 |
| Price to Sales Ratio | 2.53 |
| Price to Cash Ratio | 0.71 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 1.54M |
| Average Volume (1 week) | 6.24k |
| Average Volume (1 Month) | 23.17k |
| 52 Week Change | 19.42% |
| 52 Week High | 5.20 |
| 52 Week Low | 2.78 |
| Spread (Intraday) | 0.18 (4.31%) |
| Company Name | Xenetic Biosciences Inc |
| Address |
3273 e warm springs road las vegas, nevada 89120 |
| Website | https://www.xeneticbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
